A high-ranking Brazilian delegation visited HZB

On 16 May 2022, HZB received a delegation from the Brazilian Ministry of Research, Technology, and Innovation.

On 16 May 2022, HZB received a delegation from the Brazilian Ministry of Research, Technology, and Innovation.

© K. Fuchs / HZB

© K. Fuchs / HZB

© K. Fuchs / HZB

© K. Fuchs / HZB

© K. Fuchs / HZB

© K. Fuchs / HZB

© K. Fuchs / HZB

© K. Fuchs / HZB

© K. Fuchs / HZB

On 16 May 2022, HZB received a delegation from the Brazilian Ministry of Science, Technology and Innovation (MCTI). Vice-Minister of Science Sergio Freitas de Almeida was visibly impressed by the many research activities being done at HZB to drive the transition to a climate-neutral energy supply in society forward.

The delegation visited HZB in advance of the 9th German–Brazilian Dialogue on Science, taking place from 17 to 20 May 2022 in Berlin. Vice-Minister Sergio Freitas de Almeida was accompanied by State Secretaries José Gontijo (Entrepreneurship and Innovation) and Marcelo Morales (Research and Scientific Training) along with other government representatives.

The delegation toured the X-ray source BESSY II which, of course, is also available to Brazilian researchers. The energy research laboratory EMIL and the new research platform for catalysis research CatLab were also on the tour programme. New catalysts are a key component for producing green hydrogen efficiently and cost-effectively, as well as alternative, sustainable fuels and green raw materials for the chemical industry. The interest of the Brazilian delegation in the development of hydrogen technologies was very high. They were also very interested in cooperation between their light source SIRIUS in Campinas (Sao Paolo) and BESSY II in Berlin.

The discussions with representatives of the Brazilian government inspired all participants to strengthen cooperation in the area of research.

sz

  • Copy link

You might also be interested in

  • Green hydrogen: MXenes shows talent as catalyst for oxygen evolution
    Science Highlight
    09.09.2024
    Green hydrogen: MXenes shows talent as catalyst for oxygen evolution
    The MXene class of materials has many talents. An international team led by HZB chemist Michelle Browne has now demonstrated that MXenes, properly functionalised, are excellent catalysts for the oxygen evolution reaction in electrolytic water splitting. They are more stable and efficient than the best metal oxide catalysts currently available. The team is now extensively characterising these MXene catalysts for water splitting at the Berlin X-ray source BESSY II and Soleil Synchrotron in France.
  • SpinMagIC: 'EPR on a chip' ensures quality of olive oil and beer
    News
    04.09.2024
    SpinMagIC: 'EPR on a chip' ensures quality of olive oil and beer
    The first sign of spoilage in many food products is the formation of free radicals, which reduces the shelf-life and the overall quality of the food. Until now, the detection of these molecules has been very costly for the food companies. Researchers at HZB and the University of Stuttgart have developed a portable, small and inexpensive 'EPR on a chip' sensor that can detect free radicals even at very low concentrations. They are now working to set up a spin-off company, supported by the EXIST research transfer programme of the German Federal Ministry of Economics and Climate Protection. The EPRoC sensor will initially be used in the production of olive oil and beer to ensure the quality of these products.
  • Review on ocular particle therapy (OPT) by international experts
    Science Highlight
    03.09.2024
    Review on ocular particle therapy (OPT) by international experts
    A team of leading experts in medical physics, physics and radiotherapy, including HZB physicist Prof. Andrea Denker and Charité medical physicist Dr Jens Heufelder, has published a review article on ocular particle therapy. The article appeared in the Red Journal, one of the most prestigious journals in the field. It outlines the special features of this form of eye therapy, explains the state of the art and current research priorities, provides recommendations for the delivery of radiotherapy and gives an outlook on future developments.